←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS51%
R&D + SG&A16%
Op Margin33%
FINANCIAL HEALTH
REVENUE
$466.8B
Growth
16%
Gross M.
49%
P/E
36.4
EV/EBITDA
27.7
Net M.
28%
FCF M.
23%
D/E
1.35
Op M.
33%
PLUG INTO YOUR DCF
Historical growth
8.7%
Analyst 5y growth
—
Forward P/E
33.2
PEG ratio
2.50
Trailing EPS
$8.70
Forward EPS
$9.50
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
MEDTrading above a mechanical base-case DCF estimate of $280.42 (default assumptions) — priced for continued strong execution.
MEDDebt/equity of 1.35 — moderate leverage.
LOWRevenue growing 16% YoY — steady, unspectacular growth.
🐂 BULL
AAPL shows revenue grew +16.4% YoY, 33% operating margin, 149% ROE, a healthy 23% free cash flow margin — a business converting growth into real profit.
🐻 BEAR
At a P/E of 36.4 and EV/EBITDA of 27.7, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.